Concussion
With more than 6 out of every 1,000 people affected, concussions are one of the most common sports injuries (5% of all sports injuries*). In the United States, between 1.6 and 3.8 million concussions occur every year**. Often underestimated and misdiagnosed, these shock injuries disrupt brain function, leading to increased and sometimes persistent cognitive risks, as well as neurodegenerative diseases*** such as chronic traumatic encephalopathy. In the absence of any specific curative treatment, care is limited to targeted interventions in the event of persistent symptoms.
* Journal of Rehabilitation Medicine, (2004)
In the sporting world, the sports mainly concerned are :
A new approach to concussion management
REGEnLIFE has defined a unique application protocol for the treatment of concussions, based on its photobiomodulation technology: TriPhotonic stimulation.
RGn550: an innovative and promising photomedical technology for concussions.
Initial results from REGEnLIFE’s RECOVERY pilot clinical study on acute concussion in athletes
RGn550 shown to be safe, well-tolerated and effective in a pilot clinical study of concussion in athletes
